Regions

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

The consortium's collaboration and partnership opportunities may be the most beneficial to the HIMSS audience, according to James Hury, the Translational Research Institute for Space Health's chief innovation officer.

Ian Shakil, founder, director and chief strategy officer at Augmedix, discusses the company's role in the evolution of medical documentation.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

James Hury, the Translational Research Institute for Space Health's deputy director and chief innovation officer explains the ways space exploration companies work with healthcare innovators to examine astronaut health and advance healthcare on the ground.

Drug development platform Quris raised another $9 million, and PharmStars is accepting applications for its accelerator cohort focused on women's health and health equity.

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

Discovering people's health-engagement activities leads to helping them manage their health, according to Praveen Deorani, senior data scientist at the Singapore Ministry of Health's Office of Healthcare Transformation.

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.

Grace Chang, cofounder and CEO of Kintsugi, says that the use of machine learning voice and biomarker technology can help spot clinical depression and anxiety in regular health discussions.